Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 1, 2009, Pages 55-61

  Furonaka, Makoto ^a   Hattori, Noboru ^a   Tanimoto, Takuya ^a   Senoo, Tadashi ^a   Ishikawa, Nobuhisa ^a   Fujitaka, Kazunori ^a   Haruta, Yoshinori ^a   Yokoyama, Akihito ^b   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; GAMMA INTERFERON; HYDROXYPROLINE; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPLATAST TOSYLATE; TRANSFORMING GROWTH FACTOR BETA; ANTIHISTAMINIC AGENT; ARYLSULFONIC ACID DERIVATIVE; CCL2 PROTEIN, MOUSE; CYTOKINE; SULFONIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG STRUCTURE; FEMALE; HISTOPATHOLOGY; JAPAN; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRACHEA;

ANIMALS; ARYLSULFONATES; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL2; CYTOKINES; FEMALE; HISTAMINE ANTAGONISTS; HYDROXYPROLINE; LUNG; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS; SULFONIUM COMPOUNDS; TH2 CELLS; TRACHEA;

EID: 59149104672     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.141721     Document Type: Article

References (31)

1. American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement: American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646-664.
2. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, and Graves DT (1992) Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 89:5371-5375.
3. Bajwa EK, Ayas NT, Schulzer M, Mak E, Ryu JH, and Malhotra A (2005) Interferon- gammalb therapy in idiopathic pulmonary fibrosis: a metaanalysis. Chest 128: 203-206.
4. Boring L, Gosling J, Cleary M, and Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897.
5. Brieland JK, Flory CM, Jones ML, Miller GR, Remick DG, Warren JS, and Fantone JC (1995) Regulation ofmonocyte chemoattractantprotein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta. Am J Respir Cell Mol Biol 12:104-109.
6. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, and Walz A (1994) Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149:655-659.
7. Denis M (1992) Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukoc Biol 52:197-201.
8. DiCosmo BF, Geba GP, Picarella D, Elias JA, Rankin JA, Stripp BR, Whitsett JA, and Flavell RA (1994) Airway epithelial cell expression of interleukin-6 in trans- genic mice: uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest 94:2028-2035.
9. Furuie H, Yamasaki H, Suga M, and Ando M (1997) Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis. Eur Respir J 10:787-794.
10. Gharaee-Kermani M, Denholm EM, and Phan SH (1996) Costimulation offibroblast collagen and transforming growth factor beta1 gene expression by monocyte che- moattractant protein-1 via specific receptors. J Biol Chem 271:17779-17784.
11. Gu L, Tseng S, Horner RM, Tam C, Loda M, and Rollins BJ (2000) Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411.
12. Iijima H, Tamura G, Hsiue TR, Liu Y, Taniguchi H, and Shirato K (1999) Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs. Am J Respir Crit Care Med 160:331-335.
13. Iyonaga K, Takeya M, Saita N, Sakamoto O, Yoshimura T, Ando M, and Takahashi K (1994) Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum Pathol 25:455-463.
14. Kaltreider HB, Byrd PK, and Curtis JL (1988) Expression of Ia by murine alveolar macrophages is upregulated during the evolution of a specific immune response in pulmonary parenchyma. Am Rev Respir Dis 137:1411-1416.
15. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, and Barrett TA (1997) Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158:4129-4136.
16. King TE Jr, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, and Schwartz DA (2005) Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest 127:171-177.
17. Knight DA, Ernst M, Anderson GP, Moodley YP, and Mutsaers SE (2003) The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? Pharmacol Ther 99:327-338.
18. 14C-suplatast tosilate (IPD-1151T) to rats. Drug Metab Pharma-cokinet 7:399-421.
19. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, and Kunkel SL (2000) Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. Exp Mol Pathol 68:77-84.
20. Matsumoto K, Hayakawa H, Ide K, Suda T, Chida K, Hashimoto H, Sato A, and Nakamura H (2002) Effects of suplatast tosilate on cytokine profile of bronchoal- veolar cells in allergic inflammation of the lung. Respirology 7:201-207.
21. Moore BB, Paine R 3rd, Christensen PJ, Moore TA, Sitterding S, Ngan R, Wilke CA, Kuziel WA, and Toews GB (2001) Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 167:4368-4377.
22. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, and King TE Jr (2004) A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350:125-133.
23. Rollins BJ (1996) Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2:198-204.
24. Shen Y, Zhao HL, Du J, Li YT, Tan F, Huang CG, and Pei G (2005) Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice. Clin Exp Pharmacol Physiol 32:1071-1077.
25. Suga M, Iyonaga K, Ichiyasu H, Saita N, Yamasaki H, and Ando M (1999) Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 14:376-382.
26. Taga T (1997) The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. Ann Med 29:63-72.
27. Wallace WA, Ramage EA, Lamb D, and Howie SE (1995) Atype 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 101:436-441.
28. Woessner JF Jr (1961) The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440 -447.
29. Yoshida M, Sakuma J, Hayashi S, Abe K, Saito I, Harada S, Sakatani M, Yamamoto S, Matsumoto N, and Kaneda Y (1995) A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor b gene. Proc Natl Acad Sci US A 92:9570 -9574.
30. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, and Phan SH (1994) Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 153:4733-4741.
31. Zhao GD, Yokoyama A, Kohno N, Sakai K, Hamada H, and Hiwada K (2000) Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness. Int Arch Allergy Immunol 121:116-122.